← Back to Clinical Trials
Recruiting NCT07133529

NCT07133529 Decision-making and Food Intake

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07133529
Status Recruiting
Phase
Sponsor German Institute of Human Nutrition
Condition Behavior
Study Type INTERVENTIONAL
Enrollment 45 participants
Start Date 2025-08-04
Primary Completion 2026-07-31

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Perceived food uncertaintyPerceived food certainty

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 45 participants in total. It began in 2025-08-04 with a primary completion date of 2026-07-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study will investigate how the expectation of food availability impacts the response to food cues, mood, interoceptive awareness, and consumption of food intake in healthy, naturally cycling women.

Eligibility Criteria

Inclusion Criteria: * Nulliparous women (age: 18-35 years) with a regular menstrual cycle (25-32 days) * Legally competent/Consent to participate * Language proficiency in German (native speaker, fluent) * Physically and mentally healthy * Body mass index (BMI) of 18.5 - 30 kg/m2 Exclusion Criteria: * Current or use of hormonal contraceptives in the previous 6 months * Current use of hormonal intra-uterine devices (IUDs) * Previous or current pregnancy * Diagnosed psychological or metabolic disorder * Former or current illnesses of: 1. Brain or mind (including anxiety disorders, depression, eating disorders, personality disorders, alcohol, drugs or drug or non-substance dependence, neurological disorders other than occasional headache, psychiatric or neurological abnomalities) 2. Heart or blood circulation/cardiovascular disease (myocardial infarction, stroke, hypertension, hypotension, having a pacemaker) 3. Gastro-intestinal disorders (e.g. colon diseases, irritable bowel syndrome, Crohn's disease) 4. Endocrine disorders (e.g. thyroid disorders) 5. Other serious past or present medical conditions (for example, metabolic syndrome, diabetes) * Other serious health problems or current severe mental or physical stress. * Blood clotting disorder * Fear of drawing blood * Severe anemia * Previously diagnosed hypoglycemia episodes * Regular intake of medication (e.g. Antidepressant/anti-anxiety medication) * Blood donation within 4 weeks before the study appointment * Intake of anticoagulant medications * illegal drug consumption * smoking or nicotine consumption * extreme athletes * vegetarians or vegans or any other dietary restrictions due to allergies or intolerances * shift workers

Contact & Investigator

Central Contact

Renée Sophie Cuntz, MSc

✉ Renee.Cuntz@dife.de

📞 +49 33 200 88 2519

Principal Investigator

Soyoung Q Park, Prof. Dr.

PRINCIPAL INVESTIGATOR

German Institute of Human Nutrition Potsdam-Rehbruecke

Frequently Asked Questions

Who can join the NCT07133529 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Behavior. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07133529 currently recruiting?

Yes, NCT07133529 is actively recruiting participants. Contact the research team at Renee.Cuntz@dife.de for enrollment information.

Where is the NCT07133529 trial being conducted?

This trial is being conducted at Nuthetal, Germany.

Who is sponsoring the NCT07133529 clinical trial?

NCT07133529 is sponsored by German Institute of Human Nutrition. The principal investigator is Soyoung Q Park, Prof. Dr. at German Institute of Human Nutrition Potsdam-Rehbruecke. The trial plans to enroll 45 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology